Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

39
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
39
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

202
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
202
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

134
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
134
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

70
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
70
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

2.7K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.7K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

182
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
182

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum IgA autoantibody profiling in systemic lupus erythematosus reveals associations with disease phenotypes.

RMD open·2026
Same author

PROducing More Evidence to Reduce Glucocorticoids in Systemic Lupus Erythematosus: Putting Patient-Reported Outcomes in the Picture.

The Journal of rheumatology·2026
Same author

Can disease activity and treatment responses be captured by a core set of domains in SLE clinical trials? An analysis of phase III belimumab trial data.

Lupus science & medicine·2026
Same author

Predictive correlates of arthritis and joint damage in systemic lupus erythematosus: a multinational prospective cohort study.

Rheumatology (Oxford, England)·2026
Same author

Discordance Between Systemic Lupus Erythematosus Disease Activity Index Domain Weights and Their Association With Organ Damage Accrual.

Arthritis care & research·2026
Same author

Demographic and clinical characteristics of patients with systemic lupus erythematosus across five registries: the LupusNet federated data network.

Lupus science & medicine·2026

Related Experiment Video

Updated: Oct 23, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.1K

Systemic lupus erythematosus: a clinical update.

Kathryn Connelly1,2, Eric F Morand1,2

  • 1Department of Rheumatology, Monash Health, Melbourne, Victoria, Australia.

Internal Medicine Journal
|August 23, 2021
PubMed
Summary

Systemic lupus erythematosus (SLE) is a complex autoimmune disease with diverse patient presentations. Understanding this heterogeneity is key for accurate diagnosis and personalized treatment strategies to improve patient outcomes.

Keywords:
diagnosissystemic lupus erythematosustherapeutics

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.2K
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

384

Related Experiment Videos

Last Updated: Oct 23, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.1K
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.2K
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

384

Area of Science:

  • Immunology
  • Rheumatology
  • Internal Medicine

Background:

  • Systemic lupus erythematosus (SLE) is a complex, multi-system autoimmune disease characterized by significant heterogeneity among patients.
  • Diverse clinical manifestations, serological abnormalities, disease progression, and therapeutic responses highlight the variability in SLE.
  • Underlying SLE development and expression involve the dysfunction of a wide array of immune pathways.

Purpose of the Study:

  • To emphasize the critical importance of recognizing patient diversity in diagnosing and treating SLE.
  • To underscore that a one-size-fits-all approach is inadequate for SLE management.
  • To highlight the multifaceted nature of optimal SLE patient care.

Main Methods:

  • This abstract does not detail specific methods but discusses the clinical and immunological aspects of SLE.
  • Focuses on the principles of diagnosis and management based on disease characteristics.
  • Emphasizes the need for individualized patient assessment.

Main Results:

  • SLE exhibits striking diversity in clinical features, serological findings, and disease course.
  • Immune pathway dysregulation is central to SLE pathogenesis.
  • Individualized management strategies are essential for effective SLE treatment.

Conclusions:

  • Accurate diagnosis and effective treatment of SLE require an appreciation of individual patient heterogeneity.
  • Optimal management necessitates identifying affected organs, assessing disease severity and activity, and tailoring immunosuppressive therapies.
  • Comprehensive care includes non-pharmacological interventions, managing comorbidities, and addressing quality of life impacts.